-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Nearly 60 percent of the world's population lives in Asian countries, but only 10 percent of genetic study participants are of
Asian descent.
The difference is even greater in psychiatric studies, where subjects are almost all of European ancestry, although the impact of severe mental illness is average across
all populations.
The lack of representation of the world's population in genetic datasets leaves out a large number of genomic variations, limiting scientists' understanding
of the biological basis of mental disorders.
A team of scientists from around the world is trying to solve this problem by conducting a genetic study
of bipolar disorder in populations from India, Pakistan, Singapore, South Korea and Taiwan.
The study, called the Asian Bipolar Disorder Gene Network (A-BIG-NET), will collect and analyze DNA, demographic, environmental and medical information
from 27,500 patients diagnosed with mental illness and 15,000 controls.
The project is led by the Broad Institute of Massachusetts Institute of Technology and Harvard University, the National Institute of Mental Health and Neuroscience of India (led by Biju Viswanath), the Indian Institute of Science (led by Bratati Kahali), the Singapore Institute of Mental Health (led by Jimmy Lee), Korea University School of Medicine (led by Heon-Jeong Lee), and National Taiwan University (Professor Po-Hsiu Kuo).
。 Together, they will recruit participants, sequence genomes, analyze data, and build a network
of rapid data sharing.
The team hopes to uncover genetic markers for bipolar disorder, which may point to the biological causes and mechanisms
of this disorder that affects 1-2% of the world's population.
By focusing on Asian populations, the scientists aim to find markers that are more common in these populations than in others, potentially highlighting the genetic roots
of the disease shared by other populations around the world.
A better understanding of the causes of bipolar disorder from this research may one day lead to new and better treatments
.
"There hasn't been any large-scale genetic studies of bipolar disorder in Asian populations," said Hailiang Huang, director of the Stanley Global Asia Program at Broad University's Stanley Center for Psychiatric Research, who is also an assistant professor
at Massachusetts General Hospital and Harvard Medical School.
"If this continues, we risk that therapeutic innovations may exclude a large portion
of the global population that is underrepresented in psychiatric genetics.
" This is a major unresolved challenge
for all of the world, including South and East Asians.
”
This new project expands on Stanley Global, a Stanley Center initiative in 2014 to diversify genetic research and include underrepresented populations around the world
.
Stanley Global launched a project called NeuroGAP-Psychosis in 2018 to study the genetics of schizophrenia in four African countries, while another project called NeuroMex is conducting the same in
Mexico.
NeuroDev is studying neurodevelopmental differences
between Kenyans and South Africans.
"Studies like A-BIG-NET have the potential to uncover rare mutation risk genes, which should have a significant impact on understanding the mechanisms of bipolar disorder, much as the SCHEMA study did for schizophrenia
.
" Because Asian populations have different genetic variants, including them in A-BIG-NET will enhance the diversity and richness of gene discovery for bipolar disorder," said
Morgan Sheng, co-director of the Stanley Center.
A-BIG-NET was inspired by NeuroGAP-Psychosis and NeuroMex to expand this genetics research to Asian countries
.
While Stanley Global has previously sequenced genomic samples from East Asian populations, A-BIG-NET expanded the work to include bipolar disorder and will study larger cohorts
.
It will also be the first known large-scale study to explore the genetics of bipolar disorder in a South Asian country and will build on the latest findings from the Stanley Center, including the first strong genetic signal
for bipolar disorder.
"This study will be an important step in increasing research equity, particularly in the field of psychiatric genetics," said
Biju Viswanath, professor of psychiatry at NIMHANS India and head of the Indian division of the study.
Wiswanath founded the Indian Clinical Association of Mental Illness and Genetics (IC-MAGIC), which conducts large-scale genetic research
on mental health.
Participants from India will be the largest group of
the study.
"The project will allow for advanced training in psychiatric genetics and attract more researchers and participants
.
" This will allow for more community participation and expand research capacity
in the region.
We will be able to understand these complex diseases globally and, more importantly, locally," said
Sanjeev Jain, NIMHANS professor and senior co-investigator of the study.
About one-third of A-BIG-NET gene samples will be sequenced by the genomic platform in Broad, and the rest will be analyzed
in their home countries.
The scientists will use a recently developed sequencing technique called the mixed genome exome (BGE), which can deeply sequence the exome (2% of the protein in human DNA) and decode the rest of the genome more broadly
.
This approach aims to increase the chances of discovering new genetic variants from global samples in a cost-effective way, allowing large numbers of samples to be sequenced
.
The team will publicly share A-BIG-NET data
through the National Mental Health Data Archive Institute (NDA) and the biphasic Exomes browser.
They will also contribute their data to the Psychiatric Genomics Alliance Bipolar Disorder Working Group and the Bipolar Disorder Sequencing Project, which will allow them to compare
their results with those of other studies focused on European populations.